SKYLAR BLUEBIRD: Open Payments
NPI 1245817733 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 68 payments from 22 companies in 2025. Trend: 2023 $1,549 · 2024 $1,131 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $203 |
| ABBVIE INC. | 12 | $168 |
| GlaxoSmithKline, LLC. | 8 | $149 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Abbott Laboratories | 5 | $134 |
| Astellas Pharma US Inc | 5 | $92 |
| Lilly USA, LLC | 4 | $60 |
| ViiV Healthcare Company | 2 | $56 |
| PFIZER INC. | 2 | $39 |
| Seqirus USA Inc | 2 | $38 |
Products named: FARXIGA, Wegovy, TRELEGY ELLIPTA, QULIPTA, Veozah, FREESTYLE LIBRE 3, MOUNJARO, UBRELVY.
Industry payments across TX — which companies pay providers there.
